tiprankstipranks
Stemcell United Ltd. (DE:USZ0)
:USZ0
Germany Market
Holding DE:USZ0?
Track your performance easily

Stemcell United Ltd. (USZ0) Stock Price & Analysis

Followers

USZ0 Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

11.20%88.80%
11.20% Insiders
― Other Institutional Investors
88.80% Public Companies and
Individual Investors

USZ0 FAQ

What was Stemcell United Ltd.’s price range in the past 12 months?
Currently, no data Available
What is Stemcell United Ltd.’s market cap?
Currently, no data Available
When is Stemcell United Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Stemcell United Ltd.’s earnings last quarter?
Currently, no data Available
Is Stemcell United Ltd. overvalued?
According to Wall Street analysts Stemcell United Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does Stemcell United Ltd. pay dividends?
    Stemcell United Ltd. does not currently pay dividends.
    What is Stemcell United Ltd.’s EPS estimate?
    Stemcell United Ltd.’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Stemcell United Ltd. have?
    Currently, no data Available
    What happened to Stemcell United Ltd.’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Stemcell United Ltd.?
    Currently, no hedge funds are holding shares in DE:USZ0
    ---

    Stemcell United Ltd. Stock Smart Score

    10
    Unlock Smart Score
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Fundamentals

    Return on Equity
    Trailing 12-Months
    Asset Growth
    -80.35%
    Trailing 12-Months

    Company Description

    Stemcell United Ltd.

    Stemcell United Ltd is a marine and agricultural biotechnology industry. Its only operating segment being sourcing, producing, marketing and selling of traditional medicines. The company's geographical segment includes Australia; Singapore; Hong Kong and China. It derives a majority of revenue from Singapore. The company's product includes Cannabis sativa; Dendrobium Officinale and Daemonorops Draco Blume.
    ---
    Popular Stocks
    ---
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis